Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

GE Healthcare Acquires Unisyn Medical Technologies’ Transactional Business

Published: Thursday, May 30, 2013
Last Updated: Thursday, May 30, 2013
Bookmark and Share
The proprietary products and services from Unisyn will be integrated into GE Healthcare’s Global Services organization.

Products and services will be offered initially to customers in the United States and Canada. Global expansion is expected to start by the end of the year. Unisyn’s Diagnostic Imaging Field Services business will operate independently under a new name.

“The combination of Unisyn’s repair expertise and GE’s scale will provide value by meeting customers’ needs with a fast, cost effective and reliable probe repair solution,” said Mike Swinford, President and CEO of Global Services for GE Healthcare. “We see this as a tremendous opportunity to further grow our Ultrasound and Services footprint globally and look forward to providing our customers a cost effective solution at every step of the Ultrasound product lifecycle.”

Ultrasound customers around the world are challenged as they struggle to manage their broad ultrasound fleet of probes. They seek low cost, high quality solutions that can increase their uptime and reduce repeated failures.

Unisyn is uniquely positioned to test and evaluate ultrasound probe failures with its proprietary FirstCall™ probe-testing device. This patented technology enables Unisyn to diagnose, repair, and thoroughly test each and every probe before shipment back to the customer. FirstCall provides objective measures of probe performance through testing the acoustic and electrical properties of ultrasound probes.

“This transaction makes great sense for our stockholders, our employees and most importantly our customers,” said Jeff Soinski, CEO of Unisyn Medical Technologies. “Our ultimate goal at Unisyn is to deliver value for our customers and together with GE our transactional business is positioned to do this better than ever before. Through this acquisition, GE Healthcare will now be able to offer customers a complete probe repair solution spanning across multiple vendor platforms as well as a broad portfolio of on-demand offerings to meet customers’ unique needs.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare to Collaborate with GlaxoSmithKline on Commercial Oncology Testing
The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
Tuesday, September 30, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Strengthens R&D Efforts in Alzheimer’s Disease
A Research Collaboration with Clino Ltd., a biotechnology venture from Tohoku University on the development of novel Tau imaging tracers.
Friday, April 13, 2012
GE Healthcare Completes Acquisition of SeqWright, Inc., Expanding Capabilities in Fast Growing Molecular Diagnostic Segment
Addition of high growth company builds on Clarient’s biopharma service capabilities and provides platform to offer sequencing-based clinical diagnostics in the future.
Thursday, April 05, 2012
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.
Wednesday, December 14, 2011
GE Healthcare to Invest $1 Billion in New Oncology Solutions
Expanding advanced cancer diagnostic and molecular imaging capabilities.
Saturday, September 17, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
Scientific News
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit
New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.
New Cell Type May Help Explain Dangerous Food Allergies
Researchers have discovered a new cell type that appears to drive life-threatening food allergies and may help explain why some people get severe allergic reactions and others do not.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos